Published in Clin Exp Immunol on February 01, 1971
Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice. Clin Exp Immunol (1973) 1.93
Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts. Ann Rheum Dis (1973) 1.06
Differential effects of immunosuppressants on lymphocyte function. J Clin Invest (1973) 0.98
The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice. Clin Exp Immunol (1977) 0.88
Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs. J Clin Invest (1975) 0.77
Treatment of S.L.E. nephritis. Br Med J (1973) 0.75
Therapeutic effect of beta-[1-phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)-DL-alanin (ZIMET 3164) on immune complex nephritis of NZB hybrid mice. Agents Actions (1979) 0.75
Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid. Can Med Assoc J (1974) 0.75
Initiation of immune responses by small lymphocytes. Nature (1962) 7.16
The carriage of immunological memory by small lymphocytes in the rat. J Exp Med (1966) 4.73
THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS. Ann Intern Med (1963) 4.22
Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med (1966) 4.19
Spontaneous auto-immune disease in NZB/BL mice. Br J Haematol (1963) 3.53
Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice. Clin Exp Immunol (1968) 2.34
Immunological function of thymus and bursa of Fabricius. Thymus lesions in an auto-immune disease of mice. Nature (1962) 2.26
Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids. Int Rev Exp Pathol (1966) 2.01
Cyclophosphamide treatment of mouse systemic lupus erythematosus. Lab Invest (1969) 1.25
A deficient development of the thymic epithelium and auto-immune disease in NZB mice. J Pathol Bacteriol (1966) 1.23
Immunosuppression by cyclophosphamide in NZB X NZW mice with lupus nephritis. Blood (1968) 1.23
6-mercaptopurine administration to NZB mice. Aust J Exp Biol Med Sci (1968) 0.97
In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest (1968) 4.01
Lymphokine stimulation of collagen accumulation. J Clin Invest (1976) 2.94
The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum (1966) 2.83
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum (1974) 2.45
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Production of interleukin 1 by human endothelial cells. J Immunol (1986) 2.27
Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27
Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26
Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet (1966) 2.19
Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum (1976) 2.18
Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum (1975) 2.09
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane. Clin Exp Immunol (1969) 2.00
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum (1976) 1.75
Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol (1987) 1.73
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Negative result: treatment of patients with rheumatoid arthritis with gamma globulin: a double-blind controlled study. Arthritis Rheum (1969) 1.63
Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57
Lymphocyte chemotactic activity of human interleukin 1. J Immunol (1984) 1.56
Immunoglobulin and specific antibody synthesis in a chronic inflammatory focus: antigen-induced synovitis. J Immunol (1969) 1.52
Studies of isolated synovial living cells of rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum (1971) 1.49
Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol (1986) 1.46
Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med (1968) 1.45
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest (1969) 1.43
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum (1973) 1.41
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol (1986) 1.41
IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum (1983) 1.39
Effect of a gold salt on the immune response. Arthritis Rheum (1967) 1.38
Viruses and the connective tissue diseases. Ann Intern Med (1971) 1.37
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum (1979) 1.36
Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum (1974) 1.34
The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice. J Immunol (1982) 1.31
Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum (1972) 1.31
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum (1986) 1.30
Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surface IgM to IgD. J Immunol (1978) 1.29
Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest (1986) 1.29
Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum (1981) 1.26
Degradation of immunoglobulins by intracellular proteases in the range of neutral pH. J Immunol (1970) 1.26
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest (1977) 1.26
Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest (1972) 1.26
Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome. Clin Exp Immunol (1977) 1.25
Nephrosis in the rat induced by rat kidney extracts. Ann N Y Acad Sci (1965) 1.24
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Response of the rheumatoid synovial membrane to exogenous immunization. J Clin Invest (1971) 1.20
Diet in the treatment of rheumatoid arthritis. Arthritis Rheum (1983) 1.17
Scleroderma and scleroderma-like disorders. Semin Arthritis Rheum (1986) 1.16
Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis Rheum (1968) 1.16
IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum (1985) 1.15
Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers. J Immunol (1986) 1.14
Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J Immunol (1977) 1.14
The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol (1978) 1.14
Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc (1987) 1.14
Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. J Clin Invest (1980) 1.13
Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide. J Immunol (1986) 1.12
Electron microscopic study of HLA-DR and monocyte/macrophage staining cells in the rheumatoid synovial membrane. Arthritis Rheum (1986) 1.12
A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies. Arthritis Rheum (1981) 1.12
Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies. J Invest Dermatol (1987) 1.11
Lymphokines in rheumatoid synovitis. Ann N Y Acad Sci (1975) 1.11
Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest (1974) 1.11
Pathophysiology of rheumatoid arthritis. Fed Proc (1973) 1.10
Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues. Arthritis Rheum (1979) 1.10
Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage. Arthritis Rheum (1976) 1.10
Cytoplasmic tubular structures in kidney biopsies in systemic lupus erythematosus. Arthritis Rheum (1969) 1.10
Rheumatoid hyperviscosity syndrome. Am J Med (1970) 1.09
An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay. Ann Intern Med (1978) 1.08
Light and electron microscopic observations on the synovitis of Reiter's disease. Arthritis Rheum (1966) 1.07
The search for Fc receptors on human tissues and human endothelial cells in culture. Proc Soc Exp Biol Med (1981) 1.07
Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol (1980) 1.06
Studies on the anti-inflammatory action of 6-mercaptopurine. J Exp Med (1968) 1.06
Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum (1981) 1.05
Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera. Arthritis Rheum (1982) 1.04
Increased superoxide generation by normal granulocytes incubated in sera from patients with psoriasis. J Invest Dermatol (1981) 1.04
Degradation of immunoglobulin G by lysosomal acid proteases. J Immunol (1970) 1.04
Basement membrane thickening of postcapillary venules and capillaries in rheumatoid synovium. Immunoelectron microscopic and electron microscopic morphometric analysis. Arthritis Rheum (1987) 1.03
Complement-fixing antibodies to bedsonia organisms in Reiter's syndrome and ankylosing spondylitis. Ann Rheum Dis (1968) 1.03